Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma via m6A-mediated epitranscriptomic regulation
Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma via m6A-mediated epitranscriptomic regulation
Hung MH, Chang CW, Wang KC, Chaisaingmongkol J, Ruchirawat M, Greten, T, Wang XW
Hepatology. 2023.
(In press)